Selection of GP. Mur antigen-negative RBC for blood recipients with anti-'Mia' records decreases transfusion reaction rates in Taiwan
ABSTRACT Objectives To evaluate the clinical significance of GP. Mur antigen‐negative blood selection for transfusion in patients with anti‐‘Mia’ records. Background The GP. Mur RBC phenotype is prevalent (7·3%) in Taiwan. Antibodies against GP. Mur (anti‐‘Mia’) are identified in 1·24% of our popula...
Saved in:
| Published in | Transfusion medicine (Oxford, England) Vol. 26; no. 5; pp. 349 - 354 |
|---|---|
| Main Authors | , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Oxford, UK
Blackwell Publishing Ltd
01.10.2016
|
| Subjects | |
| Online Access | Get full text |
| ISSN | 0958-7578 1365-3148 1365-3148 |
| DOI | 10.1111/tme.12357 |
Cover
Loading…
| Abstract | ABSTRACT
Objectives
To evaluate the clinical significance of GP. Mur antigen‐negative blood selection for transfusion in patients with anti‐‘Mia’ records.
Background
The GP. Mur RBC phenotype is prevalent (7·3%) in Taiwan. Antibodies against GP. Mur (anti‐‘Mia’) are identified in 1·24% of our population, and anti‐‘Mia’ screening using GP. Mur RBC has been routine for Taiwan's blood banks. However, due to the lack of commercial antibodies, only cross‐matching was used to prevent transfusion of GP. Mur‐positive blood to patients with anti‐‘Mia’ in most hospitals. There is still a risk of GP. Mur‐positive RBC exposure and subsequent anti‐‘Mia’‐related transfusion reactions.
Methods
Since February 2014, GP. Mur antigen‐negative RBCs identified by reaction with anti‐‘Mia’‐positive serum were selected for blood recipients with anti‐‘Mia’ records. The transfusion reactions between January 2013 and January 2014 were compared with those that occurred between February 2014 and July 2015.
Results
The transfusion reaction rate was significantly higher in anti‐‘Mia’‐positive blood recipients compared to total subjects receiving an RBC transfusion before GP. Mur‐negative donor RBC selection. After antigen‐negative RBC selection, the transfusion reaction frequency in subjects with anti‐‘Mia’ became similar to total blood recipients. IgG form anti‐‘Mia’ antibodies were present in all cases of probable anti‐‘Mia’‐related transfusion reactions. The time required for anti‐‘Mia’ boosting after transfusion was around 4–21 days.
Conclusion
Selection of GP. Mur‐negative RBC for transfusion to patients with anti‐‘Mia’ records could decrease the rate of transfusion reaction and antibody boosting. This procedure should be incorporated into blood bank routines in areas where anti‐‘Mia’ is prevalent. |
|---|---|
| AbstractList | ABSTRACT
Objectives
To evaluate the clinical significance of GP. Mur antigen‐negative blood selection for transfusion in patients with anti‐‘Mia’ records.
Background
The GP. Mur RBC phenotype is prevalent (7·3%) in Taiwan. Antibodies against GP. Mur (anti‐‘Mia’) are identified in 1·24% of our population, and anti‐‘Mia’ screening using GP. Mur RBC has been routine for Taiwan's blood banks. However, due to the lack of commercial antibodies, only cross‐matching was used to prevent transfusion of GP. Mur‐positive blood to patients with anti‐‘Mia’ in most hospitals. There is still a risk of GP. Mur‐positive RBC exposure and subsequent anti‐‘Mia’‐related transfusion reactions.
Methods
Since February 2014, GP. Mur antigen‐negative RBCs identified by reaction with anti‐‘Mia’‐positive serum were selected for blood recipients with anti‐‘Mia’ records. The transfusion reactions between January 2013 and January 2014 were compared with those that occurred between February 2014 and July 2015.
Results
The transfusion reaction rate was significantly higher in anti‐‘Mia’‐positive blood recipients compared to total subjects receiving an RBC transfusion before GP. Mur‐negative donor RBC selection. After antigen‐negative RBC selection, the transfusion reaction frequency in subjects with anti‐‘Mia’ became similar to total blood recipients. IgG form anti‐‘Mia’ antibodies were present in all cases of probable anti‐‘Mia’‐related transfusion reactions. The time required for anti‐‘Mia’ boosting after transfusion was around 4–21 days.
Conclusion
Selection of GP. Mur‐negative RBC for transfusion to patients with anti‐‘Mia’ records could decrease the rate of transfusion reaction and antibody boosting. This procedure should be incorporated into blood bank routines in areas where anti‐‘Mia’ is prevalent. To evaluate the clinical significance of GP. Mur antigen-negative blood selection for transfusion in patients with anti-'Mia ' records.OBJECTIVESTo evaluate the clinical significance of GP. Mur antigen-negative blood selection for transfusion in patients with anti-'Mia ' records.The GP. Mur RBC phenotype is prevalent (7·3%) in Taiwan. Antibodies against GP. Mur (anti-'Mia ') are identified in 1·24% of our population, and anti-'Mia ' screening using GP. Mur RBC has been routine for Taiwan's blood banks. However, due to the lack of commercial antibodies, only cross-matching was used to prevent transfusion of GP. Mur-positive blood to patients with anti-'Mia ' in most hospitals. There is still a risk of GP. Mur-positive RBC exposure and subsequent anti-'Mia '-related transfusion reactions.BACKGROUNDThe GP. Mur RBC phenotype is prevalent (7·3%) in Taiwan. Antibodies against GP. Mur (anti-'Mia ') are identified in 1·24% of our population, and anti-'Mia ' screening using GP. Mur RBC has been routine for Taiwan's blood banks. However, due to the lack of commercial antibodies, only cross-matching was used to prevent transfusion of GP. Mur-positive blood to patients with anti-'Mia ' in most hospitals. There is still a risk of GP. Mur-positive RBC exposure and subsequent anti-'Mia '-related transfusion reactions.Since February 2014, GP. Mur antigen-negative RBCs identified by reaction with anti-'Mia '-positive serum were selected for blood recipients with anti-'Mia ' records. The transfusion reactions between January 2013 and January 2014 were compared with those that occurred between February 2014 and July 2015.METHODSSince February 2014, GP. Mur antigen-negative RBCs identified by reaction with anti-'Mia '-positive serum were selected for blood recipients with anti-'Mia ' records. The transfusion reactions between January 2013 and January 2014 were compared with those that occurred between February 2014 and July 2015.The transfusion reaction rate was significantly higher in anti-'Mia '-positive blood recipients compared to total subjects receiving an RBC transfusion before GP. Mur-negative donor RBC selection. After antigen-negative RBC selection, the transfusion reaction frequency in subjects with anti-'Mia ' became similar to total blood recipients. IgG form anti-'Mia ' antibodies were present in all cases of probable anti-'Mia '-related transfusion reactions. The time required for anti-'Mia ' boosting after transfusion was around 4-21 days.RESULTSThe transfusion reaction rate was significantly higher in anti-'Mia '-positive blood recipients compared to total subjects receiving an RBC transfusion before GP. Mur-negative donor RBC selection. After antigen-negative RBC selection, the transfusion reaction frequency in subjects with anti-'Mia ' became similar to total blood recipients. IgG form anti-'Mia ' antibodies were present in all cases of probable anti-'Mia '-related transfusion reactions. The time required for anti-'Mia ' boosting after transfusion was around 4-21 days.Selection of GP. Mur-negative RBC for transfusion to patients with anti-'Mia ' records could decrease the rate of transfusion reaction and antibody boosting. This procedure should be incorporated into blood bank routines in areas where anti-'Mia ' is prevalent.CONCLUSIONSelection of GP. Mur-negative RBC for transfusion to patients with anti-'Mia ' records could decrease the rate of transfusion reaction and antibody boosting. This procedure should be incorporated into blood bank routines in areas where anti-'Mia ' is prevalent. |
| Author | Wu, K.-H. Yang, C.-A. Yeh, S.-P. Chang, J.-G. Lin, J.-A. Ho, C.-M. Chang, C.-W. |
| Author_xml | – sequence: 1 givenname: C.-A. surname: Yang fullname: Yang, C.-A. organization: Department of Laboratory Medicine, China Medical University Hospital, Taiwan, China – sequence: 2 givenname: J.-A. surname: Lin fullname: Lin, J.-A. organization: Department of Laboratory Medicine, China Medical University Hospital, Taiwan, China – sequence: 3 givenname: C.-W. surname: Chang fullname: Chang, C.-W. organization: Department of Laboratory Medicine, China Medical University Hospital, Taiwan, China – sequence: 4 givenname: K.-H. surname: Wu fullname: Wu, K.-H. organization: Division of Pediatric Hematology-Oncology, Children's Hospital, Taiwan, China – sequence: 5 givenname: S.-P. surname: Yeh fullname: Yeh, S.-P. organization: College of Medicine, China Medical University, Taiwan, China – sequence: 6 givenname: C.-M. surname: Ho fullname: Ho, C.-M. organization: Department of Laboratory Medicine, China Medical University Hospital, Taiwan, China – sequence: 7 givenname: J.-G. surname: Chang fullname: Chang, J.-G. email: d6781@mail.cmuh.org.tw, d6781@mail.cmuh.org.tw organization: Department of Laboratory Medicine, China Medical University Hospital, Taiwan, China |
| BookMark | eNo9UE1PGzEQtSqQGqCH_gPf6GWDP-L17rFENC1KCqKLkHqxvOsxNWzsYDsN-QH8724S1LnMaN578zTvBB354AGhz5SM6VAXeQljyriQH9CI8lIUnE6qIzQitagKKWT1EZ2k9EQI5axmI_T2C3rosgseB4tnt2O8WEesfXaP4AsPjzq7v4DvLqfYhojbPgSDI3Ru5cDnhDcu_9nTi_OF0-c7KESTsIEugk6QcI7aJ7tOO4thdfCKOg-Q87jRbqP9GTq2uk_w6b2fovtvV830ezG_mf2Yfp0XbvhNFnUreW2kJLatpWlNRelEMqalpoa0kkFrK2EtnYA1kpSClaY0sjZdy1ouLOWn6Mvh7iqGlzWkrJYuddD32kNYJ0UrLgQpq7ocqBcH6sb1sFWr6JY6bhUlapezGnJW-5xVs7jaD4OiOChcyvD6X6Hjsyoll0I9_Jyphonr3009UxP-D4r7hKw |
| ContentType | Journal Article |
| Copyright | 2016 British Blood Transfusion Society 2016 British Blood Transfusion Society. |
| Copyright_xml | – notice: 2016 British Blood Transfusion Society – notice: 2016 British Blood Transfusion Society. |
| DBID | BSCLL 7X8 |
| DOI | 10.1111/tme.12357 |
| DatabaseName | Istex MEDLINE - Academic |
| DatabaseTitle | MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1365-3148 |
| EndPage | 354 |
| ExternalDocumentID | TME12357 ark_67375_WNG_T25JZT9G_4 |
| Genre | article |
| GroupedDBID | --- .3N .GA .Y3 05W 0R~ 10A 123 1OB 1OC 29Q 31~ 33P 36B 3SF 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5HH 5LA 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHHS AANLZ AAONW AAQQT AASGY AAXRX AAZKR ABCQN ABCUV ABDBF ABEML ABJNI ABPVW ABQWH ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACGFO ACGFS ACGOF ACMXC ACPOU ACSCC ACXBN ACXQS ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADOZA ADXAS ADZMN AEEZP AEGXH AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFEBI AFFPM AFGKR AFPWT AFZJQ AHBTC AHEFC AIACR AIAGR AITYG AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN AMBMR AMYDB ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BSCLL BY8 C45 CAG COF CS3 D-6 D-7 D-E D-F DCZOG DPXWK DR2 DRFUL DRMAN DRSTM DU5 EAD EAP EAS EBC EBD EBS EBX EGARE EJD EMB EMK EMOBN EPT ESX EX3 F00 F01 F04 F5P FEDTE FUBAC FZ0 G-S G.N GODZA H.X HF~ HGLYW HVGLF HZI HZ~ IHE IX1 J0M J5H K48 KBYEO L7B LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ O66 O9- OIG OVD P2P P2W P2X P2Z P4B P4D PALCI Q.N Q11 QB0 Q~Q R.K RIWAO RJQFR ROL RX1 SAMSI SUPJJ SV3 TEORI TUS UB1 V8K W8V W99 WBKPD WHWMO WIH WIJ WIK WOHZO WOW WQJ WRC WUP WVDHM WXI WXSBR XG1 YFH YUY ZZTAW ~IA ~WT AAHQN AAIPD AAMMB AAMNL AANHP AAYCA ACRPL ACUHS ACYXJ ADNMO AEFGJ AEYWJ AFWVQ AGHNM AGQPQ AGXDD AGYGG AIDQK AIDYY ALVPJ 7X8 |
| ID | FETCH-LOGICAL-i1117-9b739d770fb97dbd8114722a7a1d0b72ebf85ff14efd706526d6d79dcb2b35f13 |
| IEDL.DBID | DR2 |
| ISSN | 0958-7578 1365-3148 |
| IngestDate | Fri Jul 11 02:55:54 EDT 2025 Wed Aug 20 07:25:33 EDT 2025 Wed Oct 30 09:51:04 EDT 2024 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 5 |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-i1117-9b739d770fb97dbd8114722a7a1d0b72ebf85ff14efd706526d6d79dcb2b35f13 |
| Notes | ArticleID:TME12357 ark:/67375/WNG-T25JZT9G-4 istex:84AE13AADAFA97232B37C5B853B9CC71D8CAC8D1 ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| PQID | 1835506896 |
| PQPubID | 23479 |
| PageCount | 6 |
| ParticipantIDs | proquest_miscellaneous_1835506896 wiley_primary_10_1111_tme_12357_TME12357 istex_primary_ark_67375_WNG_T25JZT9G_4 |
| PublicationCentury | 2000 |
| PublicationDate | 2016-10 October 2016 20161001 |
| PublicationDateYYYYMMDD | 2016-10-01 |
| PublicationDate_xml | – month: 10 year: 2016 text: 2016-10 |
| PublicationDecade | 2010 |
| PublicationPlace | Oxford, UK |
| PublicationPlace_xml | – name: Oxford, UK |
| PublicationTitle | Transfusion medicine (Oxford, England) |
| PublicationTitleAlternate | Transfusion Med |
| PublicationYear | 2016 |
| Publisher | Blackwell Publishing Ltd |
| Publisher_xml | – name: Blackwell Publishing Ltd |
| References | Huang, C.H. & Blumenfeld, O.O. (1991) Molecular genetics of human erythrocyte MiIII and MiVI glycophorins. Use of a pseudoexon in construction of two delta-alpha-delta hybrid genes resulting in antigenic diversification. The Journal of Biological Chemistry, 266, 7248-7255. Lin, M. (2005) Transfusion Medicine (in Chinese) (3rd edn). Health and Culture Publications, Taipei. Chen, T.D., Chen, D.P., Wang, W.T., Sun, C.F. (2014) MNSs blood group glycophorin variants in Taiwan: a genotype-serotype correlation study of 'Mi(a)' and St(a) with report of two new alleles for St(a). PLoS ONE, 9, e98166. Wu, K.H., Chu, S.L., Chang, J.G., Shih, M.C., Peng, C.T. (2003) Haemolytic disease of the newborn due to maternal irregular antibodies in the Chinese population in Taiwan. Transfusion Medicine, 13, 311-314. Blumberg, N., Heal, J.M. & Gettings, K.F. (2003) WBC reduction of RBC transfusions is associated with a decreased incidence of RBC alloimmunization. Transfusion, 43, 945-952. Daniels, G.L., Fletcher, A., Garratty, G. et al. (2004) Blood group terminology 2004: from the International Society of Blood Transfusion committee on terminology for red cell surface antigens. Vox Sanguinis, 87, 304-316. Heathcote, D.J., Carroll, T.E. & Flower, R.L. (2011) Sixty years of antibodies to MNS system hybrid glycophorins: what have we learned? Transfusion Medicine Reviews, 25, 111-124. Shih, M.C., Yang, L.H., Wang, N.M., Chang, J.G. (2000) Genomic typing of human red cell miltenberger glycophorins in a Taiwanese population. Transfusion, 40, 54-61. Blumenfeld, O.O. & Huang, C.H. (1995) Molecular genetics of the glycophorin gene family, the antigens for MNSs blood groups: multiple gene rearrangements and modulation of splice site usage result in extensive diversification. Human Mutation, 6, 199-209. Wu, K.H., Chang, J.G., Lin, M., Shih, M.C., Lin, H., Lee, C.C., Peng, C.T., Tsai, C.H. (2002) Hydrops foetalis caused by anti-Mur in first pregnancy--a case report. Transfusion Medicine, 12, 325-327. Vongsakulyanon, A., Kitpoka, P., Kunakorn, M., Srikhirin, T. (2015) Miltenberger blood group typing by real-time polymerase chain reaction (qPCR) melting curve analysis in Thai population. Transfusion Medicine, 25, 393-398. Broadberry, R.E. & Lin, M. (1996) The distribution of the MiIII (Gp.Mur) phenotype among the population of Taiwan. Transfusion Medicine, 6, 145-148. Lo, S.C., Chang, J.S., Lin, S.W., Lin, D.T. (2002) Immunological characterization of anti-Mi(a), a red blood cell alloantibody, in Taiwan. Vox Sanguinis, 83, 162-164. Cheng, G., Hui, C.H., Lam, C.K., Hal, S.Y., Wong, L., Mak, K.H., Lin, C.K. (1995) Haemolytic transfusion reactions due to Mi-antibodies; need to include MiltenbergerIII positive cells in pre-transfusion antibody screening in Hong Kong. Clinical and Laboratory Haematology, 17, 183-184. Hsu, K., Lin, Y.C., Chang, Y.C., Chan, Y.S., Chao, H.P., Lee, T.Y., Lin, M. (2013) A direct blood polymerase chain reaction approach for the determination of GP.Mur (Mi.III) and other Hil + Miltenberger glycophorin variants. Transfusion, 53, 962-971. Broadberry, R.E. & Lin, M. (1994) The incidence and significance of anti-"Mia" in Taiwan. Transfusion, 34, 349-352. Chao, Y.H., Wu, K.H., Lu, J.J., Shih, M.C., Peng, C.T., Chang, C.W. (2013) Red blood cell alloimmunisation among Chinese patients with β-thalassaemia major in Taiwan. Blood Transfusion, 11, 71-74. Prathiba, R., Lopez, C.G. & Usin, F.M. (2002) The prevalence of GP Mur and anti-"Mia" in a tertiary hospital in Peninsula Malaysia. The Malaysian Journal of Pathology, 24, 95-98. Lin, M. & Broadberry, R.E. (1994) An intravascular hemolytic transfusion reaction due to anti-'Mi(a)' in Taiwan. Vox Sanguinis, 67, 320. Cooling, L. (2015) Blood groups in infection and host susceptibility. Clinical Microbiology Reviews, 28, 801-870. Poole, J., King, M.J., Mak, K.H., Liew, Y.W., Leong, S., Chua, K.M. (1991) The MiIII phenotype among Chinese donors in Hong Kong: immunochemical and serological studies. Transfusion Medicine, 1, 169-175. 2004; 87 1991; 1 2015; 25 2015; 28 1991; 266 2013; 11 1995; 17 2002; 83 2002; 12 2002; 24 2013; 53 1994; 34 2014; 27 1994; 67 2003; 13 2000; 40 2005 2011; 25 2014; 9 1995; 6 2003; 43 1996; 6 |
| References_xml | – reference: Wu, K.H., Chang, J.G., Lin, M., Shih, M.C., Lin, H., Lee, C.C., Peng, C.T., Tsai, C.H. (2002) Hydrops foetalis caused by anti-Mur in first pregnancy--a case report. Transfusion Medicine, 12, 325-327. – reference: Huang, C.H. & Blumenfeld, O.O. (1991) Molecular genetics of human erythrocyte MiIII and MiVI glycophorins. Use of a pseudoexon in construction of two delta-alpha-delta hybrid genes resulting in antigenic diversification. The Journal of Biological Chemistry, 266, 7248-7255. – reference: Hsu, K., Lin, Y.C., Chang, Y.C., Chan, Y.S., Chao, H.P., Lee, T.Y., Lin, M. (2013) A direct blood polymerase chain reaction approach for the determination of GP.Mur (Mi.III) and other Hil + Miltenberger glycophorin variants. Transfusion, 53, 962-971. – reference: Cheng, G., Hui, C.H., Lam, C.K., Hal, S.Y., Wong, L., Mak, K.H., Lin, C.K. (1995) Haemolytic transfusion reactions due to Mi-antibodies; need to include MiltenbergerIII positive cells in pre-transfusion antibody screening in Hong Kong. Clinical and Laboratory Haematology, 17, 183-184. – reference: Daniels, G.L., Fletcher, A., Garratty, G. et al. (2004) Blood group terminology 2004: from the International Society of Blood Transfusion committee on terminology for red cell surface antigens. Vox Sanguinis, 87, 304-316. – reference: Lin, M. (2005) Transfusion Medicine (in Chinese) (3rd edn). Health and Culture Publications, Taipei. – reference: Lin, M. & Broadberry, R.E. (1994) An intravascular hemolytic transfusion reaction due to anti-'Mi(a)' in Taiwan. Vox Sanguinis, 67, 320. – reference: Shih, M.C., Yang, L.H., Wang, N.M., Chang, J.G. (2000) Genomic typing of human red cell miltenberger glycophorins in a Taiwanese population. Transfusion, 40, 54-61. – reference: Broadberry, R.E. & Lin, M. (1996) The distribution of the MiIII (Gp.Mur) phenotype among the population of Taiwan. Transfusion Medicine, 6, 145-148. – reference: Cooling, L. (2015) Blood groups in infection and host susceptibility. Clinical Microbiology Reviews, 28, 801-870. – reference: Poole, J., King, M.J., Mak, K.H., Liew, Y.W., Leong, S., Chua, K.M. (1991) The MiIII phenotype among Chinese donors in Hong Kong: immunochemical and serological studies. Transfusion Medicine, 1, 169-175. – reference: Blumberg, N., Heal, J.M. & Gettings, K.F. (2003) WBC reduction of RBC transfusions is associated with a decreased incidence of RBC alloimmunization. Transfusion, 43, 945-952. – reference: Chao, Y.H., Wu, K.H., Lu, J.J., Shih, M.C., Peng, C.T., Chang, C.W. (2013) Red blood cell alloimmunisation among Chinese patients with β-thalassaemia major in Taiwan. Blood Transfusion, 11, 71-74. – reference: Chen, T.D., Chen, D.P., Wang, W.T., Sun, C.F. (2014) MNSs blood group glycophorin variants in Taiwan: a genotype-serotype correlation study of 'Mi(a)' and St(a) with report of two new alleles for St(a). PLoS ONE, 9, e98166. – reference: Prathiba, R., Lopez, C.G. & Usin, F.M. (2002) The prevalence of GP Mur and anti-"Mia" in a tertiary hospital in Peninsula Malaysia. The Malaysian Journal of Pathology, 24, 95-98. – reference: Wu, K.H., Chu, S.L., Chang, J.G., Shih, M.C., Peng, C.T. (2003) Haemolytic disease of the newborn due to maternal irregular antibodies in the Chinese population in Taiwan. Transfusion Medicine, 13, 311-314. – reference: Heathcote, D.J., Carroll, T.E. & Flower, R.L. (2011) Sixty years of antibodies to MNS system hybrid glycophorins: what have we learned? Transfusion Medicine Reviews, 25, 111-124. – reference: Lo, S.C., Chang, J.S., Lin, S.W., Lin, D.T. (2002) Immunological characterization of anti-Mi(a), a red blood cell alloantibody, in Taiwan. Vox Sanguinis, 83, 162-164. – reference: Blumenfeld, O.O. & Huang, C.H. (1995) Molecular genetics of the glycophorin gene family, the antigens for MNSs blood groups: multiple gene rearrangements and modulation of splice site usage result in extensive diversification. Human Mutation, 6, 199-209. – reference: Vongsakulyanon, A., Kitpoka, P., Kunakorn, M., Srikhirin, T. (2015) Miltenberger blood group typing by real-time polymerase chain reaction (qPCR) melting curve analysis in Thai population. Transfusion Medicine, 25, 393-398. – reference: Broadberry, R.E. & Lin, M. (1994) The incidence and significance of anti-"Mia" in Taiwan. Transfusion, 34, 349-352. – volume: 25 start-page: 111 year: 2011 end-page: 124 article-title: Sixty years of antibodies to MNS system hybrid glycophorins: what have we learned? publication-title: Transfusion Medicine Reviews – volume: 24 start-page: 95 year: 2002 end-page: 98 article-title: The prevalence of GP Mur and anti‐"Mia" in a tertiary hospital in Peninsula Malaysia publication-title: The Malaysian Journal of Pathology – volume: 12 start-page: 325 year: 2002 end-page: 327 article-title: Hydrops foetalis caused by anti‐Mur in first pregnancy‐‐a case report publication-title: Transfusion Medicine – volume: 25 start-page: 393 year: 2015 end-page: 398 article-title: Miltenberger blood group typing by real‐time polymerase chain reaction (qPCR) melting curve analysis in Thai population publication-title: Transfusion Medicine – volume: 6 start-page: 145 year: 1996 end-page: 148 article-title: The distribution of the MiIII (Gp.Mur) phenotype among the population of Taiwan publication-title: Transfusion Medicine – volume: 83 start-page: 162 year: 2002 end-page: 164 article-title: Immunological characterization of anti‐Mi(a), a red blood cell alloantibody, in Taiwan publication-title: Vox Sanguinis – volume: 53 start-page: 962 year: 2013 end-page: 971 article-title: A direct blood polymerase chain reaction approach for the determination of GP.Mur (Mi.III) and other Hil + Miltenberger glycophorin variants publication-title: Transfusion – volume: 67 start-page: 320 year: 1994 article-title: An intravascular hemolytic transfusion reaction due to anti‐'Mi(a)' in Taiwan publication-title: Vox Sanguinis – year: 2005 – volume: 1 start-page: 169 year: 1991 end-page: 175 article-title: The MiIII phenotype among Chinese donors in Hong Kong: immunochemical and serological studies publication-title: Transfusion Medicine – volume: 17 start-page: 183 year: 1995 end-page: 184 article-title: Haemolytic transfusion reactions due to Mi‐antibodies; need to include MiltenbergerIII positive cells in pre‐transfusion antibody screening in Hong Kong publication-title: Clinical and Laboratory Haematology – volume: 27 start-page: 686 year: 2014 end-page: 687 – volume: 9 start-page: e98166 year: 2014 article-title: MNSs blood group glycophorin variants in Taiwan: a genotype‐serotype correlation study of 'Mi(a)' and St(a) with report of two new alleles for St(a) publication-title: PLoS ONE – volume: 34 start-page: 349 year: 1994 end-page: 352 article-title: The incidence and significance of anti‐"Mia" in Taiwan publication-title: Transfusion – volume: 13 start-page: 311 year: 2003 end-page: 314 article-title: Haemolytic disease of the newborn due to maternal irregular antibodies in the Chinese population in Taiwan publication-title: Transfusion Medicine – volume: 6 start-page: 199 year: 1995 end-page: 209 article-title: Molecular genetics of the glycophorin gene family, the antigens for MNSs blood groups: multiple gene rearrangements and modulation of splice site usage result in extensive diversification publication-title: Human Mutation – volume: 28 start-page: 801 year: 2015 end-page: 870 article-title: Blood groups in infection and host susceptibility publication-title: Clinical Microbiology Reviews – volume: 87 start-page: 304 year: 2004 end-page: 316 article-title: Blood group terminology 2004: from the International Society of Blood Transfusion committee on terminology for red cell surface antigens publication-title: Vox Sanguinis – volume: 40 start-page: 54 year: 2000 end-page: 61 article-title: Genomic typing of human red cell miltenberger glycophorins in a Taiwanese population publication-title: Transfusion – volume: 11 start-page: 71 year: 2013 end-page: 74 article-title: Red blood cell alloimmunisation among Chinese patients with β‐thalassaemia major in Taiwan publication-title: Blood Transfusion – volume: 43 start-page: 945 year: 2003 end-page: 952 article-title: WBC reduction of RBC transfusions is associated with a decreased incidence of RBC alloimmunization publication-title: Transfusion – volume: 266 start-page: 7248 year: 1991 end-page: 7255 article-title: Molecular genetics of human erythrocyte MiIII and MiVI glycophorins. Use of a pseudoexon in construction of two delta‐alpha‐delta hybrid genes resulting in antigenic diversification publication-title: The Journal of Biological Chemistry – volume: 27 start-page: 367 year: 2014 end-page: 390 |
| SSID | ssj0013292 |
| Score | 2.0833173 |
| Snippet | ABSTRACT
Objectives
To evaluate the clinical significance of GP. Mur antigen‐negative blood selection for transfusion in patients with anti‐‘Mia’ records.... To evaluate the clinical significance of GP. Mur antigen-negative blood selection for transfusion in patients with anti-'Mia ' records.OBJECTIVESTo evaluate... |
| SourceID | proquest wiley istex |
| SourceType | Aggregation Database Publisher |
| StartPage | 349 |
| SubjectTerms | anti-'Mia' antibody boosting GP. Mur Miltenberger type III transfusion reaction |
| Title | Selection of GP. Mur antigen-negative RBC for blood recipients with anti-'Mia' records decreases transfusion reaction rates in Taiwan |
| URI | https://api.istex.fr/ark:/67375/WNG-T25JZT9G-4/fulltext.pdf https://onlinelibrary.wiley.com/doi/abs/10.1111%2Ftme.12357 https://www.proquest.com/docview/1835506896 |
| Volume | 26 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1PSxwxFA_iofTSWqt06x-eUIqXWXZnJ5MZPKnoirAidkQphZBMkrKIs-LMonjaLyB41K-3n8T3MrvL2lPxNjDJkMnLS37v3y-M_XC5iROj0FKNbRREubGBwmM2EK2cm7biwrSoGrl3Eh-dR8eX_HKB7UxrYWp-iJnDjTTD79ek4EqXc0peXdsmFXpSJTnlahEgOgvnIgj-QmREEElAnO0TViHK4pn1REBKc3n_Bl3OY1R_yBx-Zn-mw6tzS66aw0o384d_mBvfOf4l9mkCPmG3Xi1f2IItltmH3iS8_pU9_vK34qCoYOCge9oElAPg3BNl53j0VNi_nicczvb2AdEu-LR3IIKMG6qrLIHcur4Dth6Pnnt9NR69QO0JKsF4jFraEiqPl4fkqsO3dXEFEGtFCf0CMtW_U8UKOz88yPaPgsl9DUEff0kEqRad1AjRcjoVRpsEbS0RhkqoNkpchFa7hDvXjqwzFF0NYxMbkZpch7rDXbuzyhaLQWG_MUAjkiM2tQYP08hylUa5M0ZFvKU7Do2sBvvpJSdvak4OqW6vKEVNcHlx0pVZyI9_Z2lXRg22NRWtRMWhaIgq7GBYStzL0DqLkzRusG0vqNnHpoYRikh6Ecmsd-Afvv9_0zX2EcFVXCf-rbPF6nZoNxDAVHrTr9RXH5_yDw |
| linkProvider | Wiley-Blackwell |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ba9swFD50HWx72dZdWHarCmXsxSFxLMuGvWylTXpxGJ3LymAIyZJKKHVK7bDSp_yBwR63v5dfsnPkJGR7GnszWDKWPl2-c3TOJ4BtV5g4MQot1dhGQVQYGyjcZgPRKbjpKi5Mh7KRs2E8OIkOTvnpGrxb5MI0-hBLhxvNDL9e0wQnh_TKLK8vbJsyPcUtuE03enuD6jhcOUPwVyIjh0gCUm2f6wpRHM-yKlJS6s3rP_jlKkv128zeA_i6-MEmuuS8Pal1u7j5S7vxf1vwEO7P-Sd73wyYDViz5SO4k81P2B_D90_-YhxEi40d639sM4SCYfeTauds-qO0Z14qnB1_2GFIeJmPfGekkXFJqZUVI8-ur4ClZ9Of2UjNpr9Y4wyqmPE0tbIVqz1lnpC3Dt82-RWMhCsqNipZrkbfVPkETvZ2851BML-yIRhhk0SQatFLjRAdp1NhtEnQ3BJhqITqIugitNol3LluZJ2hA9YwNrERqSl0qHvcdXtPYb0cl_YZMLQjEdPUGtxPI8tVGhXOGBXxju45tLNa8MZDJy8bWQ6prs4pSk1w-XnYl3nID77kaV9GLdhaYCtx7tCBiCrteFJJXM7QQIuTNG7BW4_U8mML2wghkh4imWe7_uH5vxfdhLuDPDuSR_vDwxdwD7lW3MQBvoT1-mpiXyGfqfVrP2x_AymR9io |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFD4aQ5p42biKblyMhBAvqdLUl0Q8wbZ2DFpNIxMTQrLs2J6qaWm1pALx1D-AxCP8vf4Sjp22Kjwh3iLFjmIfH_s7t88Az11heGoUWqrc0ogWxkYKj9lIxAUzHcWEiX018mDIj87o8Tk734BXy1qYhh9i5XDzmhH2a6_gE-PWlLy-sm1f6CluwE3K49Qv6YPTZC2EEG5ERgiRRp60fUEr5NN4Vl0RkfrJ_PoHvFwHqeGU6e3A5-X_Nckll-1prdvFt7-oG_9zALdhe4E-yetmudyBDVveha3BIr5-D75_CNfioKzI2JH-SZugIAhOvufsnM9-lPYiEIWT0zf7BOEuCXnvxDNkTHxhZUW8Xzd0wNbz2c_BSM1nv0jjCqqICSC1shWpA2Ceel8dvm2qK4inrajIqCS5Gn1R5X046x3m-0fR4sKGaIRDElGmRTczQsROZ8Jok6KxJZJECdVBkYvEapcy5zrUOuPDqwk33IjMFDrRXeY63QewWY5L-xAIWpEMwak1eJpSy1RGC2eMoizWXYdWVgteBMnJSUPKIdX1pc9RE0x-HPZlnrDjT3nWl7QFz5ailag5PhyiSjueVhI3MzTPeJrxFrwMglp9bGkZoYhkEJHMB4fhYfffmz6FrZODnnz_dvhuD24h0OJNEuAj2Kyvp_YxgplaPwmL9jd8w_Ti |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Selection+of+GP.+Mur+antigen%E2%80%90negative+RBC+for+blood+recipients+with+anti%E2%80%90%E2%80%98Mia%E2%80%99+records+decreases+transfusion+reaction+rates+in+Taiwan&rft.jtitle=Transfusion+medicine+%28Oxford%2C+England%29&rft.au=Yang%2C+C.%E2%80%90A.&rft.au=Lin%2C+J.%E2%80%90A.&rft.au=Chang%2C+C.%E2%80%90W.&rft.au=Wu%2C+K.%E2%80%90H.&rft.date=2016-10-01&rft.pub=Blackwell+Publishing+Ltd&rft.issn=0958-7578&rft.eissn=1365-3148&rft.volume=26&rft.issue=5&rft.spage=349&rft.epage=354&rft_id=info:doi/10.1111%2Ftme.12357&rft.externalDBID=10.1111%252Ftme.12357&rft.externalDocID=TME12357 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0958-7578&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0958-7578&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0958-7578&client=summon |